In these patients, local extracorporeal radiation therapy activates and promotes the maturation of antigen-presenting cells by altering various immune-related factors in cancer cells (ATP, GM-CSF, HMGB1, etc.), promoting their influx into the lymph nodes. This evidence concerns the gene CSF2 and cancer.